GlassScriptPhysician profile
Haskell Mcgill Kirkpatrick
NPI 1356384200
$2,930.91
in general payments reported to CMS, 2019-2025
38 companies · $1,653 in 2025
The $1,653 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.49 · 2020: $36.65 · 2021: $48.37 · 2022: $143 · 2023: $268 · 2024: $702 · 2025: $1,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,622.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $316.74 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Novartis Pharmaceuticals Corporation | $261.19 | 2019-2025 | |
| Kite Pharma, INC. | $245.09 | 2022-2025 | Yescarta |
| Merck Sharp & Dohme LLC | $217.15 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $201.05 | 2022-2025 | Darzalex, Rybrevant, Carvykti |
| Incyte Corporation | $183.48 | 2019-2025 | Jakafi, Monjuvi |
| Glaxosmithkline, LLC. | $167.68 | 2024-2025 | Ojjaara, Zejula, Jemperli |
| Pfizer INC. | $104.65 | 2024-2025 | |
| Abbvie INC. | $101.68 | 2022-2025 | |
| Geron Corporation | $94.30 | 2025 | Rytelo |
| Gilead Sciences, INC. | $81.42 | 2021-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $73.54 | 2025 | |
| Stemline Therapeutics INC. | $71.07 | 2024-2025 | Orserdu, Elzonris |
| Genentech USA, INC. | $68.64 | 2022-2024 | Tecentriq |
| Intuitive Surgical, INC. | $64.50 | 2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haskell Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.